Drupal.behaviors.print = function(context) {window.print();window.close();}>
Dx Focus: CDC's Dengue Fever Assay; Asuragen Grants BD License to Armored RNA Tech
June 21, 2012
Dx Focus: CDC's Dengue Fever Assay; Asuragen Grants BD License to Armored RNA Tech
Full-text access for premium subscribers only.
Existing premium subscribers
login here
.
New to GenomeWeb?
Register here
quickly.
Related Stories
FDA Clears CDC's Dengue MDx Test
June 20, 2012 / GenomeWeb Daily News
BD's Q2 Revenues Increase 4 Percent on Diagnostics Sales Strength
May 2, 2013 / GenomeWeb Daily News
Cepheid Highlights Strong Uptake of Xpert CT/NG as Q1 Revenues Rise 19 Percent
April 25, 2013 / PCR Insider
Dx Focus: BD Max Cdiff; Hologic Aptima HPV; Inostics BEAMing Tech; Veredus Labs VereFlu Test
April 11, 2013 / PCR Insider
FDA Clears BD's C. difficile Assay for BD Max System
April 9, 2013 / GenomeWeb Daily News